Visual Evoked Potentials (VEP)

Visual evoked potentials (VEPs) record the electrical response of the visual cortex to visual stimulation, providing objective evidence of optic pathway integrity. VEPs are particularly valuable for diagnosing optic neuritis (sensitive to subclinical demyelination), tracking recovery, evaluating non-organic visual loss, and assessing visual pathway function in infants and uncooperative patients. The pattern-reversal VEP, recorded over occipital scalp during visual checkerboard reversal, produces a stereotyped P100 response — the gold standard waveform for clinical evaluation. This page covers VEP technique, normal responses, abnormalities, and clinical applications.

Stimulation Methods

Pattern-Reversal VEP (Standard)

  • Checkerboard pattern with black and white squares.
  • Squares “reverse” (white becomes black and vice versa) at a regular rate (typically 1–4 Hz).
  • Each reversal is a stimulus event.
  • Pattern brightness and contrast standardized.
  • Monocular testing: patient covers one eye, stimulus to other.
  • Patient fixates on a central marker.

Flash VEP

  • Diffuse light flash stimulation.
  • Used when patient cannot cooperate with pattern (infants, severe visual loss).
  • Less reliable than pattern-reversal; larger normal variation.
  • Particularly useful for assessing visual cortex function in infants.

Pattern-Onset VEP

  • Brief presentation of a pattern, then return to uniform field.
  • Alternative when nystagmus or other ocular issues affect pattern-reversal.

Recording Setup

  • Recording electrodes over occipital scalp:
    • Active (G1): Oz (midline occipital), 2.5 cm above inion.
    • Reference (G2): Cz (vertex) or Fz (forehead).
    • Ground: Fpz (midline forehead).
  • Some labs use multiple occipital electrodes (Oz, O1, O2) for lateralization.
  • Filters: 1 Hz low-frequency, 100 Hz high-frequency.
  • Time base: 25 ms/div, total epoch 250 ms.
  • Averaging: 100+ stimuli per eye.

The P100 Response

  • The clinical hallmark VEP waveform.
  • Large positive deflection occurring at approximately 100 ms after pattern reversal.
  • Three main components in standard waveform:
    • N75: small negative wave at ~75 ms.
    • P100: large positive wave at ~100 ms (the dominant measured response).
    • N145: negative wave at ~145 ms.

Normal P100

  • Latency: typically 95–115 ms in adults.
  • Each lab establishes its own normal range based on equipment and method.
  • Side-to-side difference: usually <5 ms.
  • Amplitude: variable; less clinically useful than latency.
  • Generally similar between eyes in healthy individuals.

Abnormal VEPs

Prolonged P100 Latency

  • Most common abnormality.
  • Indicates conduction delay in the optic pathway.
  • Mechanism: demyelination slows conduction along the optic nerve.
  • Side-to-side difference >5 ms: pathologic.
  • Bilateral prolongation: suggests bilateral disease (MS, hereditary optic neuropathy).

Absent P100

  • No identifiable response.
  • Severe optic neuropathy.
  • Severe ischemic injury.
  • Compressive optic neuropathy (advanced).
  • Total optic atrophy.

Reduced P100 Amplitude

  • Less specific than latency.
  • Can result from axonal loss in the optic nerve.
  • Also influenced by pupil size, fixation, and effort.

Asymmetric Latencies

  • Unilateral prolonged P100 with normal contralateral: focal unilateral disease.
  • Often optic neuritis in MS.
  • Difference >5 ms is significant.

Clinical Applications

Multiple Sclerosis (MS)

  • Optic neuritis is a common presenting feature.
  • VEP abnormalities support diagnosis (especially in McDonald criteria).
  • 50–70% of MS patients have abnormal VEP at some point.
  • Many patients with subclinical optic involvement: normal vision but abnormal VEP.
  • Useful for demonstrating dissemination in space.
  • Recovery: latencies can improve but often residual delay persists.

Acute Optic Neuritis

  • VEP often normal in first 1–2 weeks after acute event.
  • Latency increases as inflammation evolves; can persist for months.
  • Eventual partial recovery in most.
  • Persistent prolongation: marker of demyelination.

Ischemic Optic Neuropathy

  • Acute: variable; often absent or markedly reduced amplitude.
  • Latency may be normal early (vs prolonged in optic neuritis).
  • VEP abnormality reflects axonal loss more than demyelination.

Compressive Optic Neuropathy

  • Pituitary tumor, optic nerve sheath meningioma, other masses.
  • Variable VEP findings; mix of delay and amplitude reduction.
  • Reverses with decompression in many cases.

Hereditary Optic Neuropathies

  • Leber hereditary optic neuropathy (LHON): bilateral progressive optic atrophy; mitochondrial mutation.
  • VEP: bilateral prolonged latencies and reduced amplitudes.
  • Dominant optic atrophy: similar findings.

Functional Visual Loss (Non-Organic)

  • Patient reports visual loss but VEP is normal.
  • Distinguishes from true optic pathway disease.
  • Useful in patients with inconsistent clinical findings.

Vitamin Deficiency

  • B12 deficiency, folate deficiency: rarely abnormal VEPs.
  • Wernicke encephalopathy: variable.

Toxic Optic Neuropathy

  • Methanol, ethambutol, chloramphenicol, isoniazid: can cause optic neuropathy.
  • VEP shows progressive abnormality with continued exposure.

Inflammatory Disorders

  • Neuromyelitis optica spectrum disorder (NMOSD): severe optic neuritis with profound VEP abnormalities.
  • MOG antibody-associated disease: similar.
  • Sarcoidosis, vasculitis: variable.

Pediatric and Infant VEPs

  • Flash VEP useful when pattern-reversal not feasible.
  • Maturation: VEPs develop and shorten in latency through infancy.
  • Term newborn: P100 at ~180 ms; by 6 months: ~120 ms; by 1 year: approaches adult.
  • Used in neonatal/pediatric ICU for visual pathway integrity assessment.

Specific VEP Patterns

Anterior Pathway Lesions (Optic Nerve)

  • Monocular pattern: stim each eye separately reveals unilateral or asymmetric findings.
  • Optic neuritis: prolonged P100 with relatively preserved amplitude.
  • Ischemic optic neuropathy: absent or reduced P100 with axonal pattern.

Chiasmal Lesions

  • Pituitary tumor: bitemporal hemianopia.
  • VEP: variable depending on extent.
  • Hemifield stimulation studies can detect chiasmal compression.

Retrochiasmal Lesions (Optic Tract, Radiation, Visual Cortex)

  • Monocular VEP may be normal (both retinas contribute to single hemisphere).
  • Hemifield VEP useful for retrochiasmal localization.
  • Cortical stroke causing hemianopia: VEP may be normal monocularly but abnormal hemifield.

Practical Considerations

Pupil Size and Refraction

  • Both eyes’ pupils similar; aniridia or markedly different pupils affect comparison.
  • Correct refractive errors with glasses or contacts for accurate testing.
  • Uncorrected refractive error reduces VEP amplitude and may prolong latency.

Fixation

  • Critical for accurate VEP.
  • Inattention, drowsiness reduce VEP amplitude and reliability.
  • Test cooperation important; sometimes need monitoring of eye fixation.

Reliability

  • Recommend 2 averages per condition to confirm reproducibility.
  • Inconsistent responses suggest poor attention/fixation, not pathology.

Side-to-Side Comparison

  • Most useful clinical measure.
  • Difference >5 ms or >30% amplitude difference: usually pathologic.

Reporting

A VEP report should include:

  • Indication and clinical question.
  • Pattern type (pattern-reversal, flash, etc.).
  • Average number of stimuli.
  • P100 latency for each eye.
  • Comparison to lab norms.
  • Side-to-side comparison.
  • Amplitude (if abnormal).
  • Interpretation: normal vs abnormal; if abnormal, pattern (prolongation, asymmetry, absent).
  • Clinical correlation.

🔍 Did You Know?

The persistence of prolonged P100 latency after acute optic neuritis — sometimes for life, even after complete clinical recovery — provides a window into the irreversible nature of demyelination’s effect on conduction. After acute optic neuritis, patients often experience full or near-full clinical recovery of vision within weeks to months. However, the VEP P100 latency frequently remains prolonged for years or permanently, even when visual acuity returns to baseline. This is because the conduction delay reflects residual demyelination along the optic nerve, while functional vision can be restored through redundancy, plasticity, or partial remyelination. The clinical implication is profound: a prolonged VEP P100 latency is an objective biomarker of prior demyelinating injury, even in a patient with normal current vision. This makes VEP particularly valuable in multiple sclerosis diagnosis — it can demonstrate prior optic involvement when other testing is negative, helping satisfy the “dissemination in space” requirement for diagnosis. The McDonald criteria for MS specifically allow VEP findings as evidence of optic nerve involvement. For practicing neurologists, the take-home is that a normal eye exam does not exclude prior optic neuritis — a VEP can reveal hidden optic pathway pathology, particularly in patients with otherwise atypical or subclinical MS. The same principle applies to NMOSD, MOG-associated disease, and other demyelinating conditions, where VEP supplements clinical examination and imaging.

Pitfalls and Pearls

  • Pattern-reversal VEP standard: checkerboard reversing at 1–4 Hz.
  • P100: large positive at ~100 ms; main clinical measure.
  • Normal P100 latency: typically 95–115 ms (lab-specific).
  • Side-to-side difference >5 ms: usually pathologic.
  • Prolonged P100: most common abnormality; demyelination.
  • Optic neuritis: prolonged P100 latency, often persistent after recovery.
  • Ischemic optic neuropathy: absent or reduced amplitude; axonal pattern.
  • MS: 50–70% VEP abnormalities; demonstrate dissemination in space.
  • Subclinical optic neuritis: normal vision with abnormal VEP.
  • Functional visual loss: normal VEP excludes major optic pathway disease.
  • Pediatric VEPs: maturation from ~180 ms at birth to adult by 1 year.
  • Flash VEP: for infants, uncooperative patients.
  • Refractive correction: glasses or contacts during testing.
  • Fixation important: inattention reduces amplitude.
  • Reliability check: 2 averages per condition to confirm reproducibility.
  • Hemifield testing: for retrochiasmal lesion localization.
  • VEP is sensitive, not specific: abnormality requires clinical correlation.

References

  1. Holder GE. Visual evoked potentials. Pract Neurol. 2004;4(2):78-91.
  2. Walsh P, Kane N, Butler S. The clinical role of evoked potentials. J Neurol Neurosurg Psychiatry. 2005;76(suppl 2):ii16-ii22.
  3. Aminoff MJ, ed. Aminoff’s Electrodiagnosis in Clinical Neurology. 6th ed. Elsevier; 2012.
  4. Thompson HS, Corbett JJ, Cox TA. How to measure the relative afferent pupillary defect. Surv Ophthalmol. 1981;26(1):39-42.
  5. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121-127.
  6. Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109(12):1673-1678.